Joanna Moore

1.1k total citations
22 papers, 486 citations indexed

About

Joanna Moore is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Joanna Moore has authored 22 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 11 papers in Epidemiology and 9 papers in Pharmacology. Recurrent topics in Joanna Moore's work include Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Joanna Moore is often cited by papers focused on Drug-Induced Hepatotoxicity and Protection (9 papers), Liver Disease and Transplantation (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). Joanna Moore collaborates with scholars based in United Kingdom, United States and Denmark. Joanna Moore's co-authors include Stuart J. Forbes, Benjamin M. Stutchfield, Kenneth J. Simpson, Peter Hayes, Gerry Robins, Darren G. Craig, Baltasar Lucendo‐Villarin, Alison C. MacKinnon, Dagmara Szkolnicka and David C. Hay and has published in prestigious journals such as Scientific Reports, Journal of Hepatology and Neuroreport.

In The Last Decade

Joanna Moore

20 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Moore United Kingdom 11 204 135 123 116 88 22 486
Chia-Yun Lai Taiwan 13 128 0.6× 187 1.4× 101 0.8× 145 1.3× 38 0.4× 35 544
Alexander Weymann United States 10 152 0.7× 149 1.1× 144 1.2× 169 1.5× 25 0.3× 13 527
Kengo Kawai Japan 11 181 0.9× 342 2.5× 130 1.1× 87 0.8× 29 0.3× 26 584
Yuanji Ma China 11 166 0.8× 260 1.9× 112 0.9× 70 0.6× 29 0.3× 37 531
Maria Ruart Spain 7 189 0.9× 258 1.9× 124 1.0× 81 0.7× 39 0.4× 9 478
Mike A. Leonis United States 14 210 1.0× 84 0.6× 157 1.3× 102 0.9× 63 0.7× 19 497
Lukas Geisler Germany 9 144 0.7× 249 1.8× 216 1.8× 97 0.8× 35 0.4× 17 535
Nwe Ni Than United Kingdom 12 350 1.7× 455 3.4× 115 0.9× 154 1.3× 24 0.3× 25 664
Nobuhito Taniki Japan 14 223 1.1× 286 2.1× 131 1.1× 62 0.5× 27 0.3× 43 589
Carlos Sanz‐García Spain 10 89 0.4× 297 2.2× 218 1.8× 55 0.5× 44 0.5× 20 542

Countries citing papers authored by Joanna Moore

Since Specialization
Citations

This map shows the geographic impact of Joanna Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Moore more than expected).

Fields of papers citing papers by Joanna Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Moore. The network helps show where Joanna Moore may publish in the future.

Co-authorship network of co-authors of Joanna Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Moore. A scholar is included among the top collaborators of Joanna Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Moore. Joanna Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernal, William, Rhiannon Taylor, Ian Rowe, et al.. (2024). Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation. The Lancet Regional Health - Europe. 46. 101067–101067. 6 indexed citations
2.
Ott, Peter, Thomas Damgaard Sandahl, Aftab Ala, et al.. (2024). Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets. JHEP Reports. 6(8). 101115–101115. 6 indexed citations
3.
Burke, Laura, Μαρίνα Καρακάντζα, Maria Kerr, et al.. (2024). Mechanistic insights from a pilot exploratory study of the dynamic proteomic changes during plasma exchange in patients with acute liver failure. Transfusion and Apheresis Science. 64(1). 104028–104028.
4.
Bernal, William, Tasneem Pirani, Banwari Agarwal, et al.. (2024). Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort. Journal of Hepatology. 82(4). 615–621. 7 indexed citations
5.
Hwang, Seonghwan, et al.. (2023). Novel treatment of acute and acute‐on‐chronic liver failure: Interleukin‐22. Liver International. 45(3). e15619–e15619. 10 indexed citations
6.
7.
Schilsky, Michael L., Anna Członkowska, Massimo Zuin, et al.. (2022). Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial. ˜The œLancet. Gastroenterology & hepatology. 7(12). 1092–1102. 41 indexed citations
8.
9.
Καρακάντζα, Μαρίνα, et al.. (2021). P043 Exploratory proteomic analysis of systemic changes in ALF patients undergoing PEX. A32.1–A32. 1 indexed citations
10.
11.
Lodge, Peter, Magdy Attia, Giles J. Toogood, et al.. (2020). Non-directed altruistic living liver donation: Evaluation and outcomes. HPB. 22. S350–S351. 1 indexed citations
12.
Fraser, Alasdair R., Chloe Pass, Paul S. Burgoyne, et al.. (2017). Development, functional characterization and validation of methodology for GMP-compliant manufacture of phagocytic macrophages: A novel cellular therapeutic for liver cirrhosis. Cytotherapy. 19(9). 1113–1124. 31 indexed citations
13.
Moore, Joanna, Alison C. MacKinnon, Tak Yung Man, et al.. (2016). Patients with the worst outcomes after paracetamol (acetaminophen)‐induced liver failure have an early monocytopenia. Alimentary Pharmacology & Therapeutics. 45(3). 443–454. 16 indexed citations
14.
Szkolnicka, Dagmara, Baltasar Lucendo‐Villarin, Joanna Moore, et al.. (2016). Reducing Hepatocyte Injury and Necrosis in Response to Paracetamol Using Noncoding RNAs. Stem Cells Translational Medicine. 5(6). 764–772. 37 indexed citations
15.
16.
Vliegenthart, A. D. Bastiaan, Jonathan M. Shaffer, Joanna I. Clarke, et al.. (2015). Comprehensive microRNA profiling in acetaminophen toxicity identifies novel circulating biomarkers for human liver and kidney injury. Scientific Reports. 5(1). 15501–15501. 102 indexed citations
17.
Moore, Joanna, Alison C. MacKinnon, Caroline Pope, et al.. (2015). Phenotypic and functional characterization of macrophages with therapeutic potential generated from human cirrhotic monocytes in a cohort study. Cytotherapy. 17(11). 1604–1616. 41 indexed citations
18.
Moore, Joanna, et al.. (2013). Acute kidney injury in acute liver failure: a review. Expert Review of Gastroenterology & Hepatology. 7(8). 701–712. 43 indexed citations
19.
Moore, Joanna, et al.. (2010). Advances in celiac disease. Current Opinion in Gastroenterology. 27(2). 112–118. 31 indexed citations
20.
Pioro, Erik P., et al.. (1998). Neuronal pathology in the wobbler mouse brain revealed by in vivo proton magnetic resonance spectroscopy and immunocytochemistry. Neuroreport. 9(13). 3041–3046. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chia-Yun Lai Breakdown of academic impact, for papers by Alexander Weymann Breakdown of academic impact, for papers by Kengo Kawai Breakdown of academic impact, for papers by Yuanji Ma Breakdown of academic impact, for papers by Maria Ruart Breakdown of academic impact, for papers by Mike A. Leonis Breakdown of academic impact, for papers by Lukas Geisler Breakdown of academic impact, for papers by Nwe Ni Than Breakdown of academic impact, for papers by Nobuhito Taniki Breakdown of academic impact, for papers by Carlos Sanz‐García
Rankless by CCL
2026